Publications by authors named "Jay Tuttle"

Claim this Profile
M
Mirikizumab Regulates Genes Involved in Ulcerative Colitis Disease Activity and Anti-TNF Resistance: Results From a Phase 2 Study.
Boyd Steere, Jochen Schmitz, Nick Powell, Richard Higgs, Klaus Gottlieb, Jay L Tuttle

Clin Transl Gastroenterol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis. Reply.
Jay Tuttle, Paul Emery, Ajay Nirula

N Engl J Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis.
Jay Tuttle, Edit Drescher, Jesus Abraham Simón-Campos, Paul Emery, Maria Greenwald

N Engl J Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitis.
Marla C Dubinsky, Vipul Jairath, Brian G Feagan, April N Naegeli, Jay Tuttle

BMJ Open Gastroenterol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination.
Robert J Benschop, Jay L Tuttle, Lin Zhang, Josh Poorbaugh, Nicole L Kallewaard

Sci Transl Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease.
Bruce E Sands, Laurent Peyrin-Biroulet, Jaroslaw Kierkus, Peter D R Higgins, Monika Fischer, Jay L Tuttle

Gastroenterology· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative Colitis.
William J Sandborn, Marc Ferrante, Bal R Bhandari, Elina Berliba, Toshifumi Hibi, Jay L Tuttle

Clin Gastroenterol Hepatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative clinical trial design and delivery: a phase 3 COVID-19 post-exposure prophylaxis study in skilled nursing and assisted living facilities (BLAZE-2).
Jack Knorr, Jay L Tuttle, Janelle A Sabo, Dawn H East, Karen L Price

Trials· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.
Myron S Cohen, Ajay Nirula, Mark J Mulligan, Richard M Novak, Mary Marovich, Jay L Tuttle

JAMA· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.
William J Sandborn, Marc Ferrante, Bal R Bhandari, Elina Berliba, Brian G Feagan, Jay L Tuttle

Gastroenterology· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer.
Lee S Rosen, Jonathan W Goldman, Alain P Algazi, P Kellie Turner, Brian Moser, Jay Tuttle

Clin Cancer Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia.
Saroj Vadhan-Raj, Rafat Abonour, Jonathan W Goldman, David A Smith, Christopher A Slapak, Jay L Tuttle

J Hematol Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired collateral artery development in spontaneously hypertensive rats.
Jay L Tuttle, Bridget M Sanders, Harold M Burkhart, Steven W Fath, Kimberly A Kerr

Microcirculation· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired collateral development in mature rats.
Jay L Tuttle, Tara L Hahn, Bridget M Sanders, Frank A Witzmann, Steven J Miller

Am J Physiol Heart Circ Physiol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis